Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours

Fig. 1

The expression status of the RIPK2 gene in different cancers or specific cancer subtypes was analyzed through TIMER2. The figure showed that RIPK2 expression in most malignant tumour tissues was higher than that in normal tissues, and it was statistically significant. (*P < 0.05; **P < 0.01; ***P < 0.001)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us